Physician profile
John H Braxton
NPI 1073568655
$4,456.25
in general payments reported to CMS, 2019-2025
20 companies · $97.00 in 2025
The $97.00 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $423 · 2021: $297 · 2022: $1,578 · 2023: $1,055 · 2024: $855 · 2025: $97.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,006.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,489.11 | 2021-2025 | Tisseel, Floseal |
| Biomerieux INC | $1,042.08 | 2022 | |
| Edwards Lifesciences Corporation | $446.61 | 2020-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $264.74 | 2019-2020 | |
| Getinge USA Sales, LLC | $160.75 | 2020 | |
| Lemaitre Vascular, INC. | $155.51 | 2023-2024 | Restoreflow, Artegraft Vascular Graft |
| Kls-Martin L.P. | $125.00 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.16 | 2023 | Jardiance |
| W. L. Gore & Associates, INC. | $112.51 | 2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Actelion Pharmaceuticals US, INC. | $99.01 | 2022 | |
| Innovation Technologies INC | $97.50 | 2022 | |
| Abbott Laboratories | $95.50 | 2024 | Epic |
| Artivion, INC. | $60.00 | 2019 | |
| Abiomed | $57.27 | 2023-2024 | Impella |
| Silk Road Medical, INC. | $34.60 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.00 | 2023 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $19.63 | 2021 | |
| Atricure, INC. | $16.62 | 2023 | |
| Angiodynamics, INC. | $15.65 | 2024 | Angiovac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Braxton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.